pharmaphorum Podcast

Driving the drug discovery pipeline: The value of organ-on-a-chip MPS

22 Apr 2025

Contributed by Lukas

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tomasz Kostriezewski, CSO at CN Bio, about single organ-on-a-chip technology and ...

Intelligent regulatory compliance and improved patient outcomes

16 Apr 2025

Contributed by Lukas

Across the life sciences, Regulatory Affairs (RA) teams and their colleagues in Quality and Safety are stretched beyond their limits as already imposs...

Prevention for a healthier, more productive society

15 Apr 2025

Contributed by Lukas

In a new pharmaphorum podcast, recorded during Anthropy 2025: Rebooting Britain, web editor Nicole Raleigh spoke with David Gillen, chief medical offi...

Safeguarding the pharmaceutical supply chain

02 Apr 2025

Contributed by Lukas

As we hear of the volcanic and seismic activity taking place in Iceland this week, pharmaphorum turns back to a conversation with Dean Alms, CPO of Ar...

For the continuum of mental health we need a whole system, holistic 'healthspan'

31 Mar 2025

Contributed by Lukas

If we don’t address the mental health of young people, that mental health challenge will advance into the adult population of tomorrow. What can be ...

IRA updates and making sense of the chaos in Washington, with Alice Valder Curran

20 Mar 2025

Contributed by Lukas

Last year, Alice Valder Curran, a partner at Hogan Lovells and a healthcare policy expert in Washington, D.C. joined host Jonah Comstock on the pharma...

GenAI and the revolution of drug development

05 Mar 2025

Contributed by Lukas

It takes around seven years to develop a new drug and bring it to market. With the advent of GenAI, businesses in the life sciences sector can speed u...

Patient-focused manufacturing models for personalised therapies

28 Feb 2025

Contributed by Lukas

Unique, patient-focused manufacturing models are needed to scale up innovative cell therapies for cancer and one company, CTMC, is challenging the sta...

On specialty pharmacies and prior authorisations

26 Feb 2025

Contributed by Lukas

Prior authorisations (or PAs) have long put a burden on pharmacy and medical practices, ultimately causing delays for patients.  In a new podcast, we...

Paediatric rare diseases: Children are not small adults

20 Feb 2025

Contributed by Lukas

Around 75% of rare diseases are diagnosed in childhood, with most before the age of two. With 30% of rare disease patients dying before the age of fiv...

Defining, building, and implementing in the next wave of biopharma R&D

13 Feb 2025

Contributed by Lukas

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with two PharmaLex experts about navigating complex R&D processes to unleash the n...

Insights from JP Morgan Healthcare 2025: Key trends shaping the pharma industry

06 Feb 2025

Contributed by Lukas

The JP Morgan Healthcare Conference remains one of the most influential events for the life sciences sector, setting the stage for major deal-making, ...

‘Show me the molecule’ – On synthetic biology and cutting through AI hype

04 Feb 2025

Contributed by Lukas

Therapeutic antibodies are a vital weapon in combating diseases such as cancer, but developing these treatments through conventional methods is slow a...

Simulated clinical trial populations and AI scalability

30 Jan 2025

Contributed by Lukas

AI might still be in the modish buzzword stage, but discussions exploring the potential for its scaling within life sciences are critical. In a new ph...

Rare disease and the women's health gap

23 Jan 2025

Contributed by Lukas

For women with rare diseases, they often face a double jeopardy, where many of the symptoms they experience can be confused with and misdiagnosed as m...

From science fiction to reality: AI in drug development

15 Jan 2025

Contributed by Lukas

With about 92% of new drugs failing in human clinical trials, pharma companies face tremendous financial losses and, more importantly, development and...

Precision medicine, NGS, and the quantum leap in biomarkers

18 Dec 2024

Contributed by Lukas

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs ...

Seeking effective, safe treatment for all with precision dosing

11 Dec 2024

Contributed by Lukas

In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Dr Victoria Richon, CEO of Entact Bio, a company focused on the small molecu...

Seeking effective, safe treatment for all with precision dosing

03 Dec 2024

Contributed by Lukas

Modern medicine moves ever more to precision, personalised medicine, and precision dosing is critical in a world that recognises biological individual...

CAR-T therapies: Faster, better, cheaper

26 Nov 2024

Contributed by Lukas

In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics. Working in ...

Looking to history to prepare for America’s uncertain future

19 Nov 2024

Contributed by Lukas

Since the results of the US election, the news has been awash with what the future might hold under a second Trump Administration, particularly within...

Next gen wearables: Transforming remote patient care

12 Nov 2024

Contributed by Lukas

Virtual wards (also known as hospital at home) allow patients to get the care they need at home safely and conveniently, rather than being in hospital...

From neurosurgery to focused ultrasound: Not if, but when

05 Nov 2024

Contributed by Lukas

Therapeutic or focused ultrasound began being applied to neurologic conditions less than a decade ago, but its potential in a wide spectrum of brain a...

A journey from personal to public: Digital health passports today

29 Oct 2024

Contributed by Lukas

A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both p...

Access to genomic surveillance: Open science and public health

16 Oct 2024

Contributed by Lukas

The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens. The technology proved vital in aiding understanding...

Advancing Precision Care For All

09 Oct 2024

Contributed by Lukas

Precision medicine is oft spoken about these days, as it is finally addressing the elephant in the room: one size – or, more appropriately, one dose...

Investment outlook: Key takeaways from LSX USA

04 Oct 2024

Contributed by Lukas

Investment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and accelerating the developme...

Oncology today: Eversana and pharmaphorum at ESMO 2024

25 Sep 2024

Contributed by Lukas

The ESMO congress always disseminates the latest results of cancer research, a vibrant gathering and sharing of the latest data, communicating the nex...

Medicare drug pricing negotiations: What comes next?

12 Sep 2024

Contributed by Lukas

Last month, the US Centers for Medicare and Medicaid Services released the negotiated prices for the first 10 drugs subject to the drug negotiation p...

The Life Sciences Generative AI Council and a sustainable technological future

05 Sep 2024

Contributed by Lukas

The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance the use of GenAI in life ...

Can self-navigating ADCs replace chemotherapy in the future?

28 Aug 2024

Contributed by Lukas

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Brian Fiske, chief scientific officer of Mythic Therapeutics, about minimising si...

Structuring the unstructured: Deterministic AI and white box data cleanliness

20 Aug 2024

Contributed by Lukas

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Jane Reed, director of life sciences at Linguamatics, an IQVIA company, to discus...

People need to know how to use AI now

13 Aug 2024

Contributed by Lukas

With the implementation of advancing technologies in industry comes the parallel need for suitable upskilling of the workforce – but this doesn’t ...

Chronic cough and the patient voice

06 Aug 2024

Contributed by Lukas

Chronic cough impacts up to 10% of the adult population and has a physical, psychological, and social impact on patients’ lives. Farrell Simon, chie...

Approaching the regulatory world with passion: CERs and EU MDR processes

31 Jul 2024

Contributed by Lukas

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Ethan Drower, co-founder and CEO of Cite Medical Solutions, a company providing f...

Patient engagement throughout the product lifecycle

25 Jul 2024

Contributed by Lukas

One of the things that makes patient engagement for pharma companies so challenging is that it's not something that can be added to one step of a proc...

The empowerment of data and predictive outcome models

23 Jul 2024

Contributed by Lukas

In today’s podcast, web editor Nicole Raleigh speaks with Carolyn Ward, director of clinical strategy at Particle Health Inc, a data transformation ...

The burden of diabetic vision loss in the West

18 Jul 2024

Contributed by Lukas

In today’s podcast, web editor Nicole Raleigh welcomes Dr Catherine Beech, CEO of Exonate, for a discussion on retinal vascular disease and a potent...

Tips for on-time tech transfers that stay below budget

18 Jul 2024

Contributed by Lukas

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialis...

Clinical trial trends and the rise of site networks

11 Jul 2024

Contributed by Lukas

We've recently passed the midpoint of 2024, so it's a good time to check in on trends – in this case, trends in the clinical trial space. In today's...

A spectrum of obesity requires precision

10 Jul 2024

Contributed by Lukas

In this latest pharmaphorum podcast, web editor Nicole Raleigh speaks with Michael Kyle, chief medical officer at Currax Pharmaceuticals – a company...

The power and potential of regenerative medicine

02 Jul 2024

Contributed by Lukas

The field of muscle stem cell research has been tangibly developing over the decades and in today’s pharmaphorum podcast wed editor Nicole Raleigh s...

Leveraging data and AI for clinical trial success

28 Jun 2024

Contributed by Lukas

In today’s pharmaphorum podcast, Orr Inbar, co-founder and CEO of QuantHealth, a Tel Aviv-based AI-powered clinical trial design company, discusses ...

The future of fertility and the vaginal microbiome

25 Jun 2024

Contributed by Lukas

In a new episode of the pharmaphorum podcast - recorded back in March, during Women’s History Month - web editor Nicole Raleigh spoke with Johan van...

Sustainable innovation for patients, people, and planet

21 Jun 2024

Contributed by Lukas

Sustainability is all important for the planet and its people, and in today’s podcast web editor Nicole Raleigh speaks with Harriet Lewis, director ...

The new frontier of microbiome-directed human health

18 Jun 2024

Contributed by Lukas

The microbiome is ever more frequently spoken about of late, and so the pharmaphorum podcast invited Leo Grady, founder and CEO of Jona, to speak abou...

Global medicines and the future outlook

13 Jun 2024

Contributed by Lukas

In a conversation held earlier in the year as the four-year anniversary of the pandemic approached, the pharmaphorum podcast had as guest Murray Aitke...

Purity, potency, and safety – affordably – in stem cell therapy

11 Jun 2024

Contributed by Lukas

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such tr...

The art of software

05 Jun 2024

Contributed by Lukas

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Rob Pears, VP and head of automotive, manufacturing, and life scien...

Move over CAR-T: The potential of NK cells in cell therapy

30 May 2024

Contributed by Lukas

On today’s podcast, Dr. Fred Aslan, CEO of Artiva Biosciences, joins host Jonah Comstock to talk more about this newer avenue in cell therapy. They ...

Working for a mature form of genomic medicines

29 May 2024

Contributed by Lukas

In a new episode of the pharmaphorum podcast, Rahul Kakkar, CEO of gene editing company Tome, speaks with web editor Nicole Raleigh about programmable...

Challenges and opportunities in synthetic clinical trials

23 May 2024

Contributed by Lukas

On today’s episode Web Sun, president and cofounder of Komodo Health and Tracy Mayne, SVP regulatory and life sciences research at Slipstream IT, ta...

The commercialisation of quantum science in pharma

21 May 2024

Contributed by Lukas

In today’s podcast, web editor Nicole Raleigh speaks with PASQAL’S technical business developer Europe, Krisztian Benyo, PhD, about the pharma app...

Conference report: Reuters Pharma Europe

16 May 2024

Contributed by Lukas

In this special edition of the pharmaphorum podcast, the tables have turned as Jonah Comstock puts editors Eloise McLennan and Nicole Raleigh in the h...

In vitro gametogenesis: the science has to be right, and it has to be safe

14 May 2024

Contributed by Lukas

Today’s podcast sees web editor Nicole Raleigh speak with Dr Mark Leondires, founder and medical director at Illume Fertility, who shares his own jo...

Proving ROI for digital endpoints

09 May 2024

Contributed by Lukas

Jennifer Goldsack of DiME talks in this podcast about the ROI for digital endpoints for pharma. Data shows digital endpoints drives meaningful engagem...

Clinical trials: their design, location, and, potentially, their simulation

08 May 2024

Contributed by Lukas

Clinical trials, their design and location, and these days their simulation, are the focus of today’s podcast with Dr Gen Li, founder and president ...

Pace, acceleration, and precision are the name of the game

02 May 2024

Contributed by Lukas

Security and privacy within biotech are critical points of consideration and discussion as the industry continues to innovate at speed, and it is such...

Technology working as the puzzle piece to bring better outcomes to patients

30 Apr 2024

Contributed by Lukas

While at Reuters Pharma Europe in Barcelona the other week, pharmaphorum web editor Nicole Raleigh spoke with Florian Schnappauf, VP of enterprise com...

Is precision psychiatry possible?

25 Apr 2024

Contributed by Lukas

On today’s podcast, host Jonah Comstock is joined by Dr Amit Etkin, founder and CEO of Alto Neuroscience, a recently IPO'd biotech that wants to bri...

Encouraging early engagement to revitalise Europe’s pharmaceutical landscape

23 Apr 2024

Contributed by Lukas

In an on-site interview at Reuters Pharma Europe in Barcelona, this week’s podcast saw Tommy Bramley, SVP of market access and healthcare consulting...

Predictions for AI in mental health in the coming year

18 Apr 2024

Contributed by Lukas

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes Dr Carl Marci, chief psychiatrist and managing director of mental hea...

Fixing clinical trial data management

11 Apr 2024

Contributed by Lukas

It’s 2024 and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen an...

Harnessing the velocity of biopharmaceutical advances

09 Apr 2024

Contributed by Lukas

On today's episode of the podcast CEO and co-founder of 908 Devices Kevin Knopp joins as guest, discussing how such acceleration is by virtue of techn...

Conference report: Reuters Pharma USA

04 Apr 2024

Contributed by Lukas

Last week, pharmaphorum Editor in Chief Jonah Comstock traveled to Philadelphia for Reuters Pharma USA. On today’s podcast, he chats with guest host...

The future of AI: Machine learning working together with scientific expertise

02 Apr 2024

Contributed by Lukas

In a new episode of the pharmaphorum podcast recorded live on site at WIRED Health in London in March, web editor Nicole Raleigh spoke with Elise de R...

Understanding the politics of drug pricing in the United States

28 Mar 2024

Contributed by Lukas

Everyone says they want more affordable drugs for patients that need them, but people disagree quite a bit on who's to blame for the current status qu...

Female leadership and lessening disease burden

26 Mar 2024

Contributed by Lukas

As Women’s History Month comes to its final week, today’s podcast sees web editor Nicole Raleigh in conversation with Debra Weiss, COO of the Bill...

The unique clinical trial challenges faced by digital therapeutics

21 Mar 2024

Contributed by Lukas

On today’s podcast, host Jonah Comstock is joined by Meri Beckwith, cofounder of Lindus Health, a next-gen CRO that includes digital therapeutics am...

The unmentionables: Challenging inequalities in women’s health

19 Mar 2024

Contributed by Lukas

As Women’s History Month continues, pharmaphorum web editor Nicole Raleigh welcomed a group of expert individuals onto the podcast to discuss not ju...

The next chapter for AI protein structure prediction

14 Mar 2024

Contributed by Lukas

On today’s pharmaphorum podcast, Glen Gowers, cofounder of Basecamp Research, gets into the company’s recent pre-print paper and how it improves u...

Avoiding the data swamp: The transformative power of AI

12 Mar 2024

Contributed by Lukas

In the latest episode of the pharmaphorum podcast, host Nicole Raleigh speaks (virtually) with Nathan Clark, founder and CEO of Ganymede, a modern dat...

How natural language processing can make a difference in pharma

07 Mar 2024

Contributed by Lukas

On today’s podcast, host Jonah Comstock welcomes Jane Reed, director of life sciences at IQVIA NLP, the new name for recent IQVIA acquisition Lingua...

Transitioning from traditional surgical methods to the innovative use of stem cells.

05 Mar 2024

Contributed by Lukas

In today’s podcast, host Nicole Raleigh welcomes Dr Jeffrey Gross, founder of ReCELLebrate, neurological surgeon, and expert in the field of regener...

The 2024 biopharma M&A landscape: An overview

29 Feb 2024

Contributed by Lukas

It's been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimis...

Accelerating the process, transforming therapies and advancing precision medicine

27 Feb 2024

Contributed by Lukas

In this episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Dr Mohit Jain, founder and CEO of Sapient, a biomarker discovery lab prov...

Applying genetics to chemistry to find new small molecules

22 Feb 2024

Contributed by Lukas

For all the advances that have been made in it, drug discovery is still a hit or miss process, as much an art as a science. But new technologies are c...

Opening the digital front door to advanced healthcare

20 Feb 2024

Contributed by Lukas

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Dr Brigham Hyde, co-founder and CEO of Atropos Health, and Ardy Arianpou...

Pharmaceutical research in space

15 Feb 2024

Contributed by Lukas

On today’s podcast, host Jonah Comstock welcomes Christina Corridon, global lead of oncology at ZS Associates and Sandeep Sangwan, who leads the kno...

Precision medicine in mental health - one size really doesn’t fit all

13 Feb 2024

Contributed by Lukas

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomed Dr Hans Eriksson, chief medical officer at HMNC Brain Health, a precis...

Where are the pharma voices in US politics?

08 Feb 2024

Contributed by Lukas

In today’s episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Jirair Ratevosian, a candidate for California’s 30th Distr...

A clearer harmony and attractiveness for EU Clinical Trials Regulation

06 Feb 2024

Contributed by Lukas

For the latest episode of the pharmaphorum podcast, web editor Nicole Raleigh sat down with Chris Bamford, director of clinical trial regulatory manag...

Making connections and getting noticed as a biotech start-up

01 Feb 2024

Contributed by Lukas

On today's podcast, brought to you by Kadans Science Partners, host Jonah Comstock is joined by Bradley Hardiman, Astellas Pharma’s Senior Director ...

Getting down to the nitty gritty of actively creating healthier societies

30 Jan 2024

Contributed by Lukas

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Stuart Cooper, CEO of Adelphi Group, about Anthropy – a yearly event t...

How manufacturing keeps pace with innovation in cell and gene therapy

25 Jan 2024

Contributed by Lukas

On today’s podcast, host Jonah Comstock is joined by Arturo Araya, is EVP of Commercialisation at Cellares, a company that is attempting to create a...

Fixing the inequity of drug access outside of the US

23 Jan 2024

Contributed by Lukas

In this new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes guest Cem Zorluhar, CEO of Er-Kim Pharmaceuticals, for a conversat...

Key themes from JP Morgan

18 Jan 2024

Contributed by Lukas

Editor in Chief Jonah Comstock is back from San Francisco where he attended the annual JP Morgan Healthcare Conference. On today’s episode, guest ho...

Prediction is very difficult, especially if it’s about the future

16 Jan 2024

Contributed by Lukas

In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Carl Hansen, CEO of AbCellera, for a conversation on the discovery and acce...

Promoting value-added medicines and renovating old medicines smartly

11 Jan 2024

Contributed by Lukas

In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space...

Digitisation of drug R&D: Avoiding new for novelty’s sake

09 Jan 2024

Contributed by Lukas

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Aman Wasan, CEO of ArisGlobal, about the digitisation of drug research a...

The problems of animal research for human medicine and the alternatives

04 Jan 2024

Contributed by Lukas

In today’s podcast, web editor Nicole Raleigh speaks with Dr Pandora Pound, a Fellow at the OCAE and research director at the Safer Medicines Trust,...

The race to develop innovative products and supply chain solutions

30 Dec 2023

Contributed by Lukas

In the final instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Cencora’s SVP of international...

The smart-design evolution of the laboratory space

29 Dec 2023

Contributed by Lukas

In this penultimate instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Bobby Savarese, senior pr...

Investing in the gleams of positivity and hope for life sciences innovation

28 Dec 2023

Contributed by Lukas

In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment ...

Looking to the future of UK medical device exports

27 Dec 2023

Contributed by Lukas

In this second of our festive podcast series, the pharmaphorum podcast welcomed Brandon Medical CEO Keith Jackson and the Association of British Healt...

Exploring the reasons behind increasing burdens on clinical research sites

26 Dec 2023

Contributed by Lukas

In the first of a five-part festive instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Advarra’s chief product officer, E...

An investor’s perspective on bio and tech

21 Dec 2023

Contributed by Lukas

In today’s episode of the pharmaphorum podcast, host Jonah Comstock sits down for a wide-ranging conversation with Artem Trotsyuk, an investor with ...

Why digital therapeutics (DTx) are effective and safe, but not being prescribed

19 Dec 2023

Contributed by Lukas

In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Joel Morse, CEO and co-founder of Curavit Clinical Research, and Andy Molna...

AI drug discovery: Where we are and where we’re going

14 Dec 2023

Contributed by Lukas

Today’s guest is founder and CEO of Exscientia, Andrew Hopkins, who has been named a top AI innovator by TIME and was recently appointed a lifetime ...

Retaining the human element in healthcare services whilst embracing the potential of robotics

12 Dec 2023

Contributed by Lukas

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Gavin Anderson, a man of many hats all orbiting around technology ...